Endometrial Hyperplasia & Cancer Detection

Endometrial Cancer Survival Rates

• Stage at diagnosis is the most crucial factor predicting survival outcomes.
• Earlier stage detection significantly improves prognosis.

Endometrial Cancer Screening

• Routine screening is not recommended for the general population.
• Risk factors should be assessed and tailored screening strategies implemented.
• Pelvic exams and transvaginal ultrasound may be used for monitoring in high-risk individuals.

Management of Endometrial Hyperplasia

• Hysteroscopy with endometrial biopsy is the standard procedure for diagnosing and evaluating endometrial abnormalities.
• Endometrial hyperplasia without atypia is typically managed with progesterone therapy, including medications like medroxyprogesterone acetate (MPA) or progestin IUDs.

Prognosis for Stage IV Endometrial Cancer

• Stage IV endometrial cancer indicates metastatic disease and carries a poor prognosis.
• Survival rates are significantly lower compared to earlier stages.
• Treatment options often focus on palliative care to manage symptoms and improve quality of life.

Endometrial Hyperplasia and Fertility

• Women with endometrial hyperplasia who desire pregnancy should be managed individually.
• Progesterone therapy can be used to regulate the menstrual cycle and potentially facilitate conception.
• Close monitoring and regular follow-up are essential to ensure safety and optimal outcomes.

This quiz focuses on endometrial hyperplasia and its association with cancer detection. It covers the WHO classification of hyperplasia, diagnostic techniques such as histological examination, endometrial biopsy, and the use of imaging methods like transvaginal ultrasound. Test your understanding of the diagnosis and management of these conditions.